BCL
CRXT

Bracebridge Capital LLC’s Clarus Therapeutics Holdings, Inc. Common Stock CRXT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-2,002,495
Closed -$761K 101
2022
Q2
$761K Hold
2,002,495
0.12% 71
2022
Q1
$2.98M Hold
2,002,495
0.22% 32
2021
Q4
$4.87M Hold
2,002,495
0.3% 20
2021
Q3
$10.7M Buy
+2,002,495
New +$10.7M 0.94% 5